Skip to main content
. Author manuscript; available in PMC: 2007 Dec 1.
Published in final edited form as: Pharmacogenomics J. 2007 Jan 2;7(6):368–379. doi: 10.1038/sj.tpj.6500430

Table 2.

NTRK2 single nucleotide polymorphisms (SNPs) used for genotyping.

Identification Number
SNP NCBI Celera Variation Nucleotide positiona
1* rs1147198 hCV7424042 C/A 84504902
2 (LNG5) NRb NR A/G 84514790
3 rs1187325 hCV3237596 G/C 84515149
4 (LNG7) NR NR T/C 84515449
5* rs993315 hCV7424005 T/C 84517275
6* rs1187352 hCV3237603 A/G 84523011
7* rs1619120 hCV7423969 T/C 84531750
8 NR hCV3237607 T/C 84533719
9 NR hCV26567668 C/T 84545393
10 rs7041260 hCV2121698 C/G 84548082
11* rs1778934 hCV2121705 G/A 84554176
12* rs10081630 hCV2121711 T/A 84558452
13* rs2489162 hCV2121715 C/T 84563296
14* rs3780632 hCV11868468 C/T 84582342
15* rs7048278 hCV25649147 G/A 84589707
16 rs7027979 hCV11868452 C/G 84610105
17* rs1573219 hCV7422086 T/C 84617176
18* rs12555159 hCV7958799 A/G 84624386
19 rs1443444 hCV7958706 C/T 84638865
20 rs3739804 hCV7958645 G/A 84651185
21* rs1624327 hCV7958636 T/C 84658844
22 NR hCV7958628 C/T 84664800
23* rs1036914 hCV7958610 C/T 84667713
24* rs11140776 hCV1231292 G/T 84676481
25 rs11140777 hCV1231291 C/T 84676515
26* rs10868229 hCV26567734 G/A 84693116
27* rs1822420 hCV11923616 T/C 84696830
28* rs10780690 hCV7958556 T/G 84707726
29* rs3780634 hCV1231360 G/A 84718272
30* rs10780691 hCV1231358 C/T 84720807
31 rs11788168 hCV1231354 A/T 84729983
32 rs736744 hCV1231348 A/G 84743961
33* rs4304401 hCV26566813 T/C 84760065
34* rs920776 hCV7423761 T/C 84767890
35* rs1078947 hCV581246 C/T 84792806
36 rs2277192 hCV7958330 G/A 84803531
37 rs10746752 hCV185062 A/G 84825270
38* rs4504715 hCV185068 A/G 84829632
39* rs4242630 hCV237788 C/T 84841099
40 rs1565445 hCV1935385 C/T 84846625
41* rs1490404 hCV1935396 C/T 84852084
42 rs729560 hCV946149 G/A 84863859
43* rs1490403 hCV1935405 A/T 84868060
a

HapMap NCBI Build 35.

b

No record in database.

*

In addition to our genotyping results, genotypes and allele frequency data were available for these markers from HapMap Public Release #20 for the Utah sample from the Centre d’Etude du Polymorphisme Humain collection (CEU).

HHS Vulnerability Disclosure